Aimmune Therapeutics Enrolls First Patient in ARTEMIS (ARC010) European Phase 3 Clinical Trial of AR101 for the Treatment of Peanut Allergy by Carolyn Helms | Jul 5, 2017 | Portfolio News
Aimmune Therapeutics Presents European Phase 3 PALISADE Screening Data at 2017 European Academy of Allergy and Clinical Immunology (EAACI) Congress by Carolyn Helms | Jun 20, 2017 | Portfolio News
Aimmune Therapeutics Reports on Up-Dosing in Its Ongoing Phase 3 PALISADE Trial of AR101 for Peanut Allergy by Carolyn Helms | Jun 12, 2017 | Portfolio News
Collegium Announces Scientific Presentations at the 2017 International Conference on Opioids by Carolyn Helms | Jun 8, 2017 | Portfolio News
Jazz Pharmaceuticals Presents JZP-110 Data in Patients with Excessive Sleepiness Associated with Obstructive Sleep Apnea by Carolyn Helms | Jun 6, 2017 | Portfolio News
